GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » Cash, Cash Equivalents, Marketable Securities

CRH Medical (CRH Medical) Cash, Cash Equivalents, Marketable Securities : $3.9 Mil (As of Dec. 2020)


View and export this data going back to 2008. Start your Free Trial

What is CRH Medical Cash, Cash Equivalents, Marketable Securities?

CRH Medical's quarterly cash, cash equivalents, marketable securities declined from Jun. 2020 ($5.24 Mil) to Sep. 2020 ($5.10 Mil) but then stayed the same from Sep. 2020 ($5.10 Mil) to Dec. 2020 ($3.92 Mil).

CRH Medical's annual cash, cash equivalents, marketable securities declined from Dec. 2018 ($9.95 Mil) to Dec. 2019 ($6.57 Mil) and declined from Dec. 2019 ($6.57 Mil) to Dec. 2020 ($3.92 Mil).


CRH Medical Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for CRH Medical's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical Cash, Cash Equivalents, Marketable Securities Chart

CRH Medical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.51 12.49 9.95 6.57 3.92

CRH Medical Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.57 13.33 5.24 5.10 3.92

CRH Medical Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


CRH Medical  (AMEX:CRHM) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


CRH Medical Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of CRH Medical's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


CRH Medical (CRH Medical) Business Description

Industry
Traded in Other Exchanges
N/A
Address
999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1
CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Richard Bear officer: Chief Financial Officer 9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb director 7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger officer: President 2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani director, officer: Chief Executive Officer 118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin director
Todd Patrick director 9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson director 7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler director 8855 NORTHBROOK CT BURNABY A1
Edward Wright officer: Chief Financial Officer 2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4